2,723 hedge funds and large institutions have $145B invested in Pfizer in 2021 Q2 according to their latest regulatory filings, with 187 funds opening new positions, 1,279 increasing their positions, 997 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

2% more funds holding

Funds holding: 2,6662,723 (+57)

0.55% more ownership

Funds ownership: 65.76%66.31% (+0.55%)

10% less call options, than puts

Call options by funds: $2.23B | Put options by funds: $2.47B

Holders
2,723
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
70
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.23B
Puts
$2.47B
Net Calls
Net Calls Change

Top Buyers

1 +$396M
2 +$359M
3 +$207M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$179M
5
N
Natixis
France
+$173M

Top Sellers

1 -$316M
2 -$292M
3 -$182M
4
Bank of America
Bank of America
North Carolina
-$154M
5
JP Morgan Chase
JP Morgan Chase
New York
-$144M
Name Holding Trade Value Shares
Change
Change in
Stake
2001
$585K
2002
$584K
2003
$583K
2004
$583K
2005
$580K
2006
$580K
2007
$580K
2008
$578K
2009
$578K
2010
$577K
2011
$575K
2012
$574K
2013
$573K
2014
$572K
2015
$571K
2016
$571K
2017
$570K
2018
$569K
2019
$568K
2020
$566K
2021
$566K
2022
$565K
2023
$564K
2024
$563K
2025
$562K